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pathologies. Of 30 AF positive lesions we were able to deﬁne the sub-
group of 19 locations with speciﬁc spectroscopy pattern corresponding 
wit non-malignant histology. NBI bronchoscopy is not simple to inter-
pret but gives promising results in discrimination between malignant 
and benign endobronchial tissue. 
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Background: EBUS-TBNA was reported to have higher diagnostic ac-
curacy in lymph node (LN) staging of lung cancer compared to CT and 
PET. We conducted a prospective study to compare EBUS-TBNA with 
PET/CT in mediastinal LN staging, especially focused on histologic 
types of NSCLC. 
Methods: EBUS-TBNA was performed in 73 potentially operable 
NSCLC patients (pts) (M/F 60/13, median age 64 yrs). Chest CT and 
PET/CT were done before EBUS-TBNA. In case mediastinal LN me-
tastasis was not proved by EBUS-TBNA, surgery was performed. 
Results: Out of 73 pts, 34 had adenocarcinoma (ADC) and 32 had 
squamous cell ca (SCC)(large cell ca n=4, non-small cell ca unspeci-
ﬁed, n=3). One hundred twenty-six mediastinal LNs (2R = 6, 2L=1, 
4R=44, 4L=26, 7N=49) were sampled by EBUS-TBNA in 73 pts. 
EBUS-TBNA demonstrated metastasis in 34 LN stations in 23pts 
and missed 1 N2(+) patient (station 7, SCC). Overall, EBUS-TBNA 
showed higher diagnostic accuracy than PET/CT in mediastinal LN 
staging (Table, p=0.0075). EBUS-TBNA demonstrated LN metastasis 
in 3 PET (-) patients. All 3 pts had ADC. In ADC, positive predictive 
value (PPV) and negative predictive value (NPV) of PET/CT were 
81.3% and 83.3% respectively. In SCC, PPV of PET/CT was very low 
(33.3%) and NPV was high (94.1%). 
Conclusion: EBUS-TBNA is useful in mediastinal LN staging espe-
cially for the pts with mediastinal PET (-) adenocarcinoma and PET (+) 
NSCLC.
  Sensitivity Speciﬁcity PPV NPV Accuracy
Total, n=73 PET/CT 83.3(20/24) 69.3(34/49) 57.1(20/35) 89.5(34/38) 74.0(54/73)
 EBUS-TBNA 95.8(23/24) 100(49/49) 100(23/23) 98.0(49/50) 98.6(72/73)
ADC, n=34 PET/CT 81.3(13/16) 83.3(15/18) 81.3(13/16) 83.3(15/18) 82.4(28/34)
 EBUS-TBNA 100(16/16) 100(18/18) 100(16/16) 100(18/18) 100(34/34)
SCC, n=32 PET/CT 83.3(5/6) 61.5(16/26) 33.3(5/15) 94.1(16/17) 65.6(21/32)
 EBUS-TBNA 83.3(5/6) 100(26/26) 100(5/5) 96.3(26/27) 96.9(31/32)
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Backgroud: We had previously developed the possibility of use of a 
photodynamic diagnosis (PDD) system using a tumor-selective photo-
sensitizer and laser irradiation for the early detection and photodynamic 
therapy (PDT) of centrally located early lung cancers. Recently, we 
established the autoﬂuorescence diagnosis system integrated into a 
videoendoscope (SAFE-3000) as a very useful technique for the early 
diagnosis of lung cancer. 
Patients and Methods: Thirty-four patients (45 lesions) with cen-
trally located early lung cancer (Squamous cell carcinoma, carcinoma 
in situ, TisN0M0, stage 0) received PDT using the second-generation 
photosensitizer, talaporﬁn sodium (NPe6), and a diode laser (664 nm). 
Just before the PDT, we deﬁned the tumor margin accurately using the 
novel PDD system SAFE-3000 with NPe6 and a diode laser (408 nm).
Results: Red ﬂuorescence emitted from the tumor by excitation of the 
photosensitizer by the diode laser (408 nm) from SAFE-3000 allowed 
accurate determination of the tumor margin just before the PDT. The 
complete remission (CR) rate following NPe6-PDT in the cases with 
early lung cancer was 93.3% (42 /45 lesions). We also conﬁrmed the 
loss of red ﬂuoresce from the tumors immediately after the PDT using 
SAFE-3000. We conﬁrmed that all the NPe6 in the tumor had been 
excited and photobleached by the laser irradiation (664 nm) and that no 
additional laser irradiation was needed for curative treatment. 
Conclusions: This novel PDD system using SAFE-3000 and NPe6 
improved the quality and efﬁcacy of PDT and avoided misjudgment of 
the dose of the photosensitizer or laser irradiation in PDT. 
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Background: Radiofrequency ablation therapy (RFA) is widely ap-
plied for the treatment thoracic malignancies as a modality of local 
control therapy lately. RFA procedure itself is thought to be almost safe. 
However, assessment of therapeutic efﬁcacy following RFA procedure 
is not well established. 
Lately, the use of FDG-PET-CT scan has been advocated for early 
tumor diagnosis or early recurrent cancer detection in the ﬁeld of 
thoracic malignancies. Although several studies showing the beneﬁt 
of FDG-PET-CT scan in RFA for thoracic malignancies have been 
reported, optimal timing of examinations after RFA, appropriate fol-
